US Ischemic Stroke Surgery Market

The North American ischemic stroke surgery market is experiencing significant growth driven by various factors that contribute to the rising demand for advanced medical interventions. One key driver is the increasing number of patients affected by acute ischemic stroke, a condition characterized by reduced blood flow to the brain. This surge in cases has led to the adoption of innovative diagnostic technologies, such as neurological computed tomography scans (CT) and magnetic resonance imaging scans (MRI), contributing to the market's expansion.

A noteworthy aspect fueling the market is the prevalence of both acute and chronic ischemic strokes in North America. The region witnesses a substantial burden of these stroke cases, becoming a major growth factor. The aging population in North America is another significant driver, especially as individuals aged 75 and above are more susceptible to ischemic strokes. Furthermore, there has been a concerning rise in the incidence of stroke among adults below the age of 49 in the United States over the last three decades. This evolving trend highlights ischemic stroke as a growing public health concern in the country.

According to data from the Centers for Disease Control and Prevention (CDC), stroke-related cardiovascular disease caused 1 in 6 deaths in 2020. The yearly occurrence of approximately 795,000 new or recurrent strokes in the United States contributes to the prevalence of acute and chronic ischemic strokes. The consequences of this growing population of stroke survivors extend beyond individual health, impacting the nation's healthcare infrastructure at various levels. The economic and healthcare burden associated with ischemic strokes underscores the urgency for effective medical interventions and solutions.

Moreover, the data reveals a significant prevalence of ischemic strokes among seniors in 2020, emphasizing the need for advanced treatments. Consequently, there is an increasing demand for endovascular thrombectomy (ET) in North America. The American Heart Association reported that up to 20,000 patients with acute ischemic stroke in the U.S. annually meet eligibility criteria for ET based on 2018 guidelines. ET is identified as a highly beneficial therapy for acute ischemic stroke, but access to this intervention is limited to specific centers equipped with the necessary infrastructure, including procedures, support staff, equipment, and critical care units.

Recognizing the rising demand for high-quality ET, the American Heart Association/American Stroke Association has called for the swift development of stroke systems of care. This urgency is driven by the need to meet the increasing demand for ET and enhance the overall quality of stroke interventions. As a result, the North American region dominates the ischemic stroke surgery market during the forecast period due to the high demand for endovascular thrombectomy.

The North America ischemic stroke surgery market is projected to maintain robust growth, with a Compound Annual Growth Rate (CAGR) of 9.10% expected from 2022 to 2035. This anticipated growth reflects the sustained demand for advanced surgical interventions, particularly endovascular thrombectomy, as the region continues to address the challenges posed by ischemic strokes.